Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Oral Phase”

6,683 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 6,683 results

Testing effectiveness (Phase 2)Study completedNCT05197556
What this trial is testing

Evaluate the Safety and Efficacy of HSG4112 in Overweight and Obese Patients

Who this might be right for
Obesity
Glaceum 81
Early research (Phase 1)Study completedNCT00869895
What this trial is testing

A Dose-Finding Study of E7050 Administered Orally to Patients With Advanced Solid Tumors

Who this might be right for
Cancer
Eisai Inc. 60
Early research (Phase 1)Study completedNCT01156077
What this trial is testing

Pharmacokinetic (PK) Study of Oral and IV TR-701 FA in Adolescent Patients

Who this might be right for
Bacterial Infection
Trius Therapeutics LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA) 20
Early research (Phase 1)Study completedNCT02579707
What this trial is testing

Food Effect Study of AG120 in Healthy Subjects

Who this might be right for
Healthy
Agios Pharmaceuticals, Inc. 36
Early research (Phase 1)Study completedNCT02348372
What this trial is testing

Study to Evaluate the Safety, Pharmacokinetics, and Pharmacodynamics of Single Oral Doses of GSK1278863A in Healthy Subjects

Who this might be right for
Anaemia
GlaxoSmithKline 34
Early research (Phase 1)Ended earlyNCT03816839
What this trial is testing

Evaluation of Orally Administered Amcenestrant (SAR439859) in Japanese Postmenopausal Patients With Advanced Breast Cancer (AMEERA-2)

Who this might be right for
Breast Cancer
Sanofi 10
Large-scale testing (Phase 3)Study completedNCT02081300
What this trial is testing

Safety and Efficacy of Oral LPCN 1021 in Men With Low Testosterone or Hypogonadism

Who this might be right for
Male Hypogonadism
Lipocine Inc. 315
Testing effectiveness (Phase 2)Study completedNCT01532700
What this trial is testing

An Open-Label Phase 2 Study of Ofatumumab (Arzerra) in Combination With Oral GSK2110183 in the Treatment of Relapsed and Refractory Chronic Lymphocytic Leukemia (CLL)

Who this might be right for
Chronic Lymphocytic Leukemia (CLL)
University Health Network, Toronto 28
Large-scale testing (Phase 3)UnknownNCT00002653
What this trial is testing

Combination Chemotherapy With or Without Cyclophosphamide and Prednisone in Treating Older Patients With Multiple Myeloma

Who this might be right for
Multiple Myeloma and Plasma Cell Neoplasm
Medical Research Council 1,000
Early research (Phase 1)Study completedNCT02171637
What this trial is testing

Dose Escalation Study of Oral Treatment With BIBW 2992 in Patients With Advanced Solid Tumors

Who this might be right for
Neoplasms
Boehringer Ingelheim 38
Early research (Phase 1)Study completedNCT01490177
What this trial is testing

Single Center Food Allergy Oral Immunotherapy Study

Who this might be right for
Immune System Diseases
Stanford University 50
Testing effectiveness (Phase 2)Study completedNCT00076102
What this trial is testing

Pirfenidone in Children and Young Adults With Neurofibromatosis Type I and Progressive Plexiform Neurofibromas

Who this might be right for
Neurofibromatosis 1Neurofibroma, Plexiform
National Cancer Institute (NCI) 36
Testing effectiveness (Phase 2)Study completedNCT05113953
What this trial is testing

A Trial of Centanafadine Efficacy, Safety, and Tolerability in Adult Subjects With Binge Eating Disorder

Who this might be right for
Binge-Eating Disorder
Otsuka Pharmaceutical Development & Commercialization, Inc. 147
Large-scale testing (Phase 3)Study completedNCT01456195
What this trial is testing

Comparison of TAK-875 (Fasiglifam) With Placebo in Participants With Type 2 Diabetes

Who this might be right for
Diabetes Mellitus, Type 2
Takeda 421
Testing effectiveness (Phase 2)Ended earlyNCT01011439
What this trial is testing

Phase II Study Of Oral PHA-848125AC In Patients With Thymic Carcinoma

Who this might be right for
Thymic Carcinoma
Tiziana Life Sciences LTD 72
Early research (Phase 1)Study completedNCT03061981
What this trial is testing

Evaluate The Safety,Tolerability, PK and PD Of DA-1241 In Healthy Male Subjects

Who this might be right for
Diabetes Mellitus, Type 2
Dong-A ST Co., Ltd. 60
Early research (Phase 1)Study completedNCT02063230
What this trial is testing

To Assess the Pharmacokinetics, Safety and Tolerability of Selumetinib in Patients With Hepatic Impairment and Healthy Subjects

Who this might be right for
Solid Tumors
AstraZeneca 32
Testing effectiveness (Phase 2)Study completedNCT00003565
What this trial is testing

Docetaxel in Treating Patients With Solid Tumors

Who this might be right for
Bladder CancerBreast CancerHead and Neck Cancer+2 more
Alliance for Clinical Trials in Oncology 109
Early research (Phase 1)Looking for participantsNCT05367700
What this trial is testing

HS-10382 in Patients With Chronic Myeloid Leukemia.

Who this might be right for
CML, Chronic PhaseCML, Accelerated Phase
Jiangsu Hansoh Pharmaceutical Co., Ltd. 108
Early research (Phase 1)Study completedNCT00912353
What this trial is testing

AZD7268 Single Ascending Dose Study in Healthy Japanese Subjects

Who this might be right for
Healthy
AstraZeneca 56
Load More Results